FMED vs. SIVR

Last updated Jun 3, 2026

FMED (Fidelity Disruptive Medicine ETF) and SIVR (abrdn Physical Silver Shares ETF) are both exchange-traded funds - FMED is a Health & Biotech Equities fund actively managed by Fidelity, while SIVR is a Silver fund tracking the LBMA Silver Price ($/ozt). FMED is actively managed, while SIVR is passively managed. Over the past year, FMED returned 4.49% vs 115.70% for SIVR. At a 0.19 correlation, their price movements are largely independent. FMED charges 0.50%/yr vs 0.30%/yr for SIVR.

Performance

FMED vs. SIVR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fidelity Disruptive Medicine ETF (FMED) and abrdn Physical Silver Shares ETF (SIVR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, FMED achieves a -9.30% return, which is significantly lower than SIVR's 5.62% return.

FMED

• 1D: -1.51%
• 1M: -0.65%
• YTD: -9.30%
• 6M: -12.64%
• 1Y: 4.49%
• 3Y*: —
• 5Y*: —
• 10Y*: —

SIVR

• 1D: 0.48%
• 1M: -0.39%
• YTD: 5.62%
• 6M: 28.07%
• 1Y: 115.70%
• 3Y*: 46.67%
• 5Y*: 21.96%
• 10Y*: 16.08%

*Multi-year figures are annualized to reflect compound growth (CAGR)

FMED vs. SIVR - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
FMED Fidelity Disruptive Medicine ETF	-9.30%	9.69%	2.29%	-4.20%
SIVR abrdn Physical Silver Shares ETF	5.62%	145.34%	21.08%	-1.34%

Correlation

The correlation between FMED and SIVR is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.12
Correlation (All Time) Calculated using the full available price history since Jun 13, 2023	0.19

Return for Risk

FMED vs. SIVR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FMED

FMED Risk / Return Rank: 12
FMED Sharpe Ratio Rank: 12
FMED Sortino Ratio Rank: 12
FMED Omega Ratio Rank: 12
FMED Calmar Ratio Rank: 11
FMED Martin Ratio Rank: 11

SIVR

SIVR Risk / Return Rank: 52
SIVR Sharpe Ratio Rank: 58
SIVR Sortino Ratio Rank: 42
SIVR Omega Ratio Rank: 59
SIVR Calmar Ratio Rank: 60
SIVR Martin Ratio Rank: 41

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FMED vs. SIVR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity Disruptive Medicine ETF (FMED) and abrdn Physical Silver Shares ETF (SIVR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	FMED	SIVR	Difference
Sharpe ratio Return per unit of total volatility	0.24	1.98	-1.74
Sortino ratio Return per unit of downside risk	0.49	2.12	-1.63
Omega ratio Gain probability vs. loss probability	1.05	1.36	-0.31
Calmar ratio Return relative to maximum drawdown	0.27	3.00	-2.73
Martin ratio Return relative to average drawdown	0.62	6.52	-5.90
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

FMED vs. SIVR - Sharpe Ratio Comparison

The current FMED Sharpe Ratio is 0.24, which is lower than the SIVR Sharpe Ratio of 1.98. The chart below compares the historical Sharpe Ratios of FMED and SIVR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	FMED	SIVR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.24	1.98	-1.74
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.61	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.51	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.05	0.32	-0.37

Drawdowns

FMED vs. SIVR - Drawdown Comparison

The maximum FMED drawdown since its inception was -21.84%, smaller than the maximum SIVR drawdown of -75.85%. Use the drawdown chart below to compare losses from any high point for FMED and SIVR.

Drawdown Indicators

	FMED	SIVR	Difference
Max Drawdown Largest peak-to-trough decline	-21.84%	-75.85%	+54.01%
Max Drawdown (1Y) Largest decline over 1 year	-18.33%	-42.42%	+24.09%
Max Drawdown (3Y) Largest decline over 3 years	—	-42.42%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-42.42%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-42.42%	—
Current Drawdown Current decline from peak	-14.91%	-35.56%	+20.65%
Average Drawdown Average peak-to-trough decline	-7.03%	-47.86%	+40.83%
Ulcer Index Depth and duration of drawdowns from previous peaks	7.90%	19.50%	-11.60%

Volatility

FMED vs. SIVR - Volatility Comparison

The current volatility for Fidelity Disruptive Medicine ETF (FMED) is 5.65%, while abrdn Physical Silver Shares ETF (SIVR) has a volatility of 16.44%. This indicates that FMED experiences smaller price fluctuations and is considered to be less risky than SIVR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FMED	SIVR	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.65%	16.44%	-10.79%
Volatility (6M) Calculated over the trailing 6-month period	14.21%	58.28%	-44.07%
Volatility (1Y) Calculated over the trailing 1-year period	18.59%	58.97%	-40.38%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	18.39%	36.17%	-17.78%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.39%	31.86%	-13.47%

FMED vs. SIVR - Expense Ratio Comparison

FMED has a 0.50% expense ratio, which is higher than SIVR's 0.30% expense ratio.

Dividends

FMED vs. SIVR - Dividend Comparison

Neither FMED nor SIVR has paid dividends to shareholders.

Position	TTM	2025	2024
FMED Fidelity Disruptive Medicine ETF	0.00%	0.00%	0.46%
SIVR abrdn Physical Silver Shares ETF	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both FMED and SIVR in my portfolio?

FMED and SIVR have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, FMED or SIVR?

SIVR has higher volatility (16.44%) compared to FMED (5.65%). In terms of maximum drawdown, FMED dropped -21.84% vs SIVR's -75.85%.

Which ETF is better, FMED or SIVR?

On 1-year performance, SIVR leads with 115.70% vs 4.49% for FMED. On fees, SIVR is cheaper at 0.30% per year. On volatility, FMED has been the lower-risk option at 5.65%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, FMED or SIVR?

Over the 1-year period, SIVR has performed better with a 115.70% return vs 4.49%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, FMED or SIVR?

SIVR is cheaper with a 0.30% expense ratio, compared with 0.50% for FMED.

Which ETF pays a higher dividend yield, FMED or SIVR?

FMED and SIVR have nearly identical dividend yields, around 0.00%.

What is the main difference between FMED and SIVR?

FMED is categorized as Health & Biotech Equities, while SIVR is Silver. They also come from different issuers: Fidelity and abrdn. Their fees differ too: 0.50% for FMED and 0.30% for SIVR.

Which has better risk-adjusted returns?

SIVR currently has the higher Sharpe Ratio (1.98 vs 0.24), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.